Leponex

Clozapine, the active ingredient in Leponex, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia, schizoaffective disorder, and treatment‑resistant schizophrenia in adults. GNH USA supplies Leponex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clozapine is an atypical antipsychotic used primarily in the management of schizophrenia spectrum disorders.

- Schizophrenia: Reduces positive and negative symptoms in patients who have not responded adequately to other antipsychotics. - Schizoaffective disorder: Improves mood and psychotic symptoms when standard therapies are insufficient. - Treatment‑resistant schizophrenia: Provides symptom control in individuals who have failed at least two prior antipsychotic trials.

Clozapine may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects: - Sedation: Drowsiness or fatigue, especially early in treatment. - Weight gain: Increased appetite leading to modest weight increase. - Constipation: Reduced gastrointestinal motility causing infrequent stools. - Salivation: Excessive drooling, particularly at night.

Serious or Rare Side Effects: - Agranulocytosis: Severe drop in white blood cells, necessitating regular blood monitoring. - Myocarditis: Inflammation of the heart muscle that may cause chest pain or flu‑like symptoms. - Seizures: Elevated risk, particularly at higher doses. - Neuroleptic malignant syndrome: Rare syndrome with fever, muscle rigidity, and autonomic instability.

When prescribing Clozapine, clinicians should observe several safety precautions to minimize risks. - Blood monitoring: Perform baseline and regular complete blood counts to detect agranulocytosis. - Cardiac assessment: Evaluate for myocarditis with baseline and periodic ECG and troponin tests. - Dose titration: Increase dose gradually to reduce seizure risk. - Concomitant medications: Avoid drugs that lower seizure threshold or interact with clozapine metabolism. - Patient education: Inform patients about signs of infection, cardiac symptoms, and the importance of adherence to monitoring. - Store at ambient temperature: Keep tablets below 25 °C in the original container, protected from moisture and light.

Clozapine interacts with several medicines that can alter its plasma levels or increase toxicity.

Major Interactions (Avoid): - Ciprofloxacin: Inhibits CYP1A2, markedly raising clozapine concentrations. - Fluvoxamine: Strong CYP1A2 inhibitor, can cause severe clozapine toxicity. - Carbamazepine: Induces CYP enzymes, potentially reducing clozapine efficacy.

Moderate Interactions (Monitor Closely): - Valproic acid: May increase clozapine levels and risk of sedation. - Benzodiazepines: Additive central nervous system depression. - Anticholinergic agents: May worsen constipation and urinary retention.